We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

Enzyme Essential to Red Blood Cell Production and Regulation Isolated

Jun 1, 1998
Volume: 
12
Issue: 
6

A new study by researchers at St. Jude Children’s Research Hospital, published in the May 1st issue of Cell, has identified an enzyme crucial to the production of red blood cells and platelets.

Scientists have known for years that cytokines are necessary for the production and regulation of blood cells. Little is known, however, about how these cytokines work within the body to perform a function as essential and basic as blood cell production.

Researchers at St. Jude Hospital have now shown that an enzyme called Jak2 must be present so that the cyto-kine, erythropoietin, can function properly. Without the presence of Jak2, the cells that should respond to erythropoietin fail to do so.

"Our study shows that the Jak2 kinase is essential for erythropoietin to trigger the production of red blood cells," said James Ihle, PhD, chairman of the biochemistry department, St. Jude Children’s Research Hospital. "If Jak2 is not present, or not working properly, red blood cells cannot be produced, or they are produced incorrectly, as in the case of leukemia and anemia."

According to Dr. Ihle, a greater understanding of Jak2 and red blood cell production will help physicians and scientists develop therapies that can target malfunctioning cells and activate or deactivate the ability of these cells to respond to cytokines as necessary.

Jak2-Deficient Mice Compared to Healthy Mice

Dr. Ihle and a team of researchers zeroed in on the effects of Jak2 by comparing mice that lacked the Jak2 protein to healthy mice. As embryos, mice lacking Jak2 failed to respond to erythropoietin and did not produce red blood cells--proof that Jak2 is essential for processing erythropoietin. Studies of the mutant mice also demonstrated that Jak2 is needed for the proper functioning of thrombopoietin and for the production of platelets. Other cytokines, such as interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-5, and interferon-gamma, were also found to require Jak2 for their responses in cells.

 "Through this type of genetic research and therapy, we will be able to better determine why children have blood disorders. That information can help us develop new and better treatments that address specific malformations within the body’s genetic code," added Dr. Ihle.

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.